Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
clym
/
Climb Bio Inc
CLYM
Add to Watchlist
12.100
USD
+0.200
+1.68%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 08/03, 09:30 (ET)
825.03M
Market Cap
Loss
P/E TTM
Climb Bio Inc
12.100
+0.200
+1.68%
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RA Capital Management, LP
19.74%
Pontifax Venture Capital
9.09%
MPM BioImpact LLC
4.67%
T. Rowe Price Associates, Inc.
3.36%
Adar1 Capital Management LLC
2.50%
Other
60.64%
Shareholders
Shareholders
Proportion
RA Capital Management, LP
19.74%
Pontifax Venture Capital
9.09%
MPM BioImpact LLC
4.67%
T. Rowe Price Associates, Inc.
3.36%
Adar1 Capital Management LLC
2.50%
Other
60.64%
Shareholder Types
Shareholders
Proportion
Venture Capital
28.89%
Hedge Fund
14.53%
Investment Advisor
10.51%
Investment Advisor/Hedge Fund
7.74%
Research Firm
1.03%
Individual Investor
0.39%
Pension Fund
0.15%
Other
36.77%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
194
35.98M
59.67%
-6.59M
2025Q4
180
50.12M
94.21%
+7.08K
2025Q3
182
50.11M
95.00%
-5.30M
2025Q2
174
55.41M
95.70%
-2.05M
2025Q1
161
57.46M
90.60%
-8.97M
2024Q4
149
56.10M
86.82%
+979.54K
2024Q3
120
56.83M
81.50%
+4.66M
2024Q2
84
51.93M
31.41%
+31.40M
2024Q1
82
18.86M
80.37%
-3.42M
2023Q4
86
18.86M
80.98%
+125.11K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
RA Capital Management, LP
11.30M
23.66%
+7.11K
+0.06%
Jan 05, 2026
Pontifax Venture Capital
5.21M
10.9%
--
--
Mar 31, 2025
MPM BioImpact LLC
2.67M
5.59%
+2.67M
--
Dec 31, 2025
T. Rowe Price Associates, Inc.
1.92M
4.03%
+1.40M
+265.07%
Dec 31, 2025
Adar1 Capital Management LLC
1.43M
3%
+1.30M
+972.77%
Dec 31, 2025
Affinity Asset Advisors LLC
1.30M
2.72%
--
--
Dec 31, 2025
Kynam Capital Management LP
1.03M
2.15%
--
--
Dec 31, 2025
Great Point Partners, LLC
979.53K
2.05%
+979.53K
--
Dec 31, 2025
Sphera Funds Management Ltd.
932.25K
1.95%
+497.41K
+114.39%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ProShares Ultra Nasdaq Biotechnology
0.01%
iShares Biotechnology ETF
0.01%
Invesco Nasdaq Biotechnology ETF
0.01%
iShares Micro-Cap ETF
0.01%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Growth ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Neuroscience and Healthcare ETF
0%
iShares Russell 2000 Value ETF
0%
View more
ProShares Ultra Nasdaq Biotechnology
Proportion
0.01%
iShares Biotechnology ETF
Proportion
0.01%
Invesco Nasdaq Biotechnology ETF
Proportion
0.01%
iShares Micro-Cap ETF
Proportion
0.01%
Avantis US Small Cap Equity ETF
Proportion
0%
iShares Russell 2000 Growth ETF
Proportion
0%
Proshares Ultra Russell 2000
Proportion
0%
ProShares UltraPro Russell2000
Proportion
0%
iShares Neuroscience and Healthcare ETF
Proportion
0%
iShares Russell 2000 Value ETF
Proportion
0%